MarkEMailliardMD

Gastroenterology • Omaha, NE

Professor, Division of Gastroenterology and Hepatology

Join to view full profile

Dr. Mailliard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mailliard's full profile

Already have an account?

Office
Emile At 42nd St
Omaha, NE 68198
Phone+1 402-559-4015

Summary

Dr. Mark Mailliard is a gastroenterologist in Omaha, NE and is affiliated with multiple hospitals in the area, including Nebraska Medicine - Nebraska Medical Center and Veterans Affairs Nebraska-Western Iowa Health Care System. He received his medical degree from University of Nebraska College of Medicine. He specializes in general gastroenterology and hepatology, biliary tract disease, and gi endoscopy.

Education & Training

University of FloridaFellowship, Gastroenterology, 1984 - 1987
University of Nebraska Medical Center College of MedicineFellowship, Gastroenterology, 1983 - 1984
University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1981 - 1983
University of Nebraska College of MedicineClass of 1980

Certifications & Licensure

NE State Medical License 1982 - 2024
FL State Medical License 1984 - 2022
IA State Medical License 2011 - 2022
SD State Medical License Active through 2021
TX State Medical License 1996 - 2012
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Gastroenterology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (AGAF) American Gastroenterological Association, 2007
Fellow (FACG) American College of Gastroenterology

Clinical Trials

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients Start of enrollment: 2008 Apr 01
Withdrawn
Not Applicable
Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C Start of enrollment: 2009 Apr 15
Withdrawn
Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers Start of enrollment: 2009 May 01
Terminated
Early Phase 1
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network Start of enrollment: 2011 Nov 01
Completed
Study of Oral Treatments for Hepatitis C Start of enrollment: 2016 Jun 01
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

1 citations
Mortality Increased Among Hospitalized Patients with Cirrhosis Before and Following Different Waves of the COVID-19 Pandemic.
Patrick A Twohig, Kyle Scholten, Makayla Schissel, Kevin Brittan, Jason Barbaretta
Digestive Diseases and Sciences. 2023-12-01
20 citations
Cost-effectiveness of Universal and Targeted Hepatitis C Virus Screening in the United States.
Moosa Tatar, Susana Keeshin, Mark E. Mailliard, Fernando A. Wilson
JAMA Network Open. 2020-09-01
42 citations
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET Study
Jordan J. Feld, Raoel Maan, Stefan Zeuzem, Alexander Kuo, David R. Nelson
Clinical Infectious Diseases. 2016-09-15

Press Mentions

UNMC for the RecordNovember 30th, 2018

Grant Support

Amino Acid Control Of Plasma Membrane Protein SynthesisNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1993

Professional Memberships